News

AST SpaceMobile (NASDAQ: ASTS) was a bad investment from 2020 to the start of 2024. The stock woefully underperformed the S&P 500 during that stretch and went from $20 per share to $2 per share

Shares of Docusign (NASDAQ: DOCU) soared to a record high of $310 in September 2021, as pandemic-related lockdowns and social restrictions fueled explosive demand for its digital document software

Those who had the foresight to invest in Summit Therapeutics (NASDAQ: SMMT) and Madrigal Pharmaceuticals (NASDAQ: MDGL) three years ago are sitting pretty right now. Both companies have soared over

Summit Street Capital Management established a new position in Weatherford International (NASDAQ:WFRD), adding 398,661 shares valued at an estimated $27.3 million during the third quarter, according

On November 14, New York City-based Summit Street Capital Management disclosed a new position in Signet Jewelers (NYSE:SIG), acquiring 264,054 shares valued at $25.3 million, according to its latest

New York City-based Summit Street Capital Management increased its stake in Core Natural Resources (NYSE:CNR) by 81,170 shares in the third quarter, adding approximately $10.4 million in position

New York City-based Summit Street Capital Management fully exited its position in Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC), reducing holdings by 281,812 shares during the quarter and

It's been an interesting year for Bitcoin (CRYPTO: BTC), the world's largest cryptocurrency. After Donald Trump's election as president last year, Bitcoin and the rest of the crypto sector soared

Did you know that Summit Therapeutics (NASDAQ: SMMT) is one of the few publicly traded companies that has a market cap of more than $10 billion, but no revenue? With that kind of a valuation and

Sometimes, everything can seem to be going your way. And then the wheels fall off. That's the situation Summit Therapeutics (NASDAQ: SMMT) finds itself in.

Shares of the clinical-stage biotech

The state of New Hampshire just made crypto history by announcing the first-ever municipal bond backed by Bitcoin (CRYPTO: BTC). That comes just months after New Hampshire approved the first-ever

It's not possible to go back in time and invest in Nvidia or Amazon when they were still relatively small companies. However, it is possible to identify corporations that appear poised to establish

The wave of crypto optimism we've seen this year hasn't done much for Cardano (CRYPTO: ADA). The smart contract crypto's price is down 50% year over year and, at $0.41, is worth about 86% less than

The crypto market is stumbling again. Chart patterns from the first three Bitcoin (CRYPTO: BTC) halving cycles suggest that it's a little early to enter the next crypto winter, but you know what

HG Vora Capital Management, LLC reported a reduction in its Ryder System (NYSE:R) position, selling 300,000 shares for an estimated net change of $37.77 million, according to its November 14, 2025

The U.S. stock market turned sharply lower Tuesday morning in reaction to seemingly negative comments by the CEOs of Morgan Stanley (NYSE: MS) and Goldman Sachs (NYSE: GS). At the Global Financial

On November 03, 2025, Hussman Strategic Advisors reported a full exit from Check Point Software Technologies Ltd. (NASDAQ:CHKP) in Q3 2025 with an estimated $4.65 million trade.

According to a

Buying dividend stocks at low prices can have two positive benefits. The first is that if you're buying low, the yield can be higher than normal. It can provide you with some high dividend income

AST SpaceMobile (NASDAQ: ASTS) is on a mission to eliminate dead zones through direct-to-smartphone satellite technology. Its partnerships with telecom giants like AT&T and Vodafone and its massive

What if you had invested in any of the current leaders in the biotech industry before they established themselves as such? You'd have earned terrific returns. While we can't go back in time to do

Investment management company Conestoga Capital Advisors, LLC reported selling 3,896,749 shares of CCC Intelligent Solutions Holdings (NASDAQ:CCCS) for an estimated $37.69 million based on the

Explore the exciting world of Summit Therapeutics (NASDAQ: SMMT) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights

AT&T (NYSE: T) is the third-largest wireless carrier in the U.S., serving over 90 million customers. Wireless generates the majority of the company's roughly $120 billion in annual revenue. AT&T

Docusign (NASDAQ: DOCU) stock went public in 2018 at $29, and by September 2021, it had soared more than tenfold to a record high of $310. The COVID-19 pandemic fueled incredible demand for the

Telecom giant AT&T (NYSE: T) has a simple growth strategy: Win high-value customers who use its wireless and fiber services together. The company picked up plenty of those so-called "converged"